Cargando…

Pramipexole in patients with early Parkinson's disease (PROUD): a randomised delayed-start trial

BACKGROUND: In models of dopaminergic neuronal loss, the dopamine agonist pramipexole has exhibited neuroprotective properties. The Pramipexole On Underlying Disease (PROUD) study was designed to identify whether early versus delayed pramipexole initiation has clinical and neuroimaging benefits in p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Schapira, Anthony HV, McDermott, Michael P, Barone, Paolo, Comella, Cynthia L, Albrecht, Stefan, Hsu, Helen H, Massey, Daniel H, Mizuno, Yoshikuni, Poewe, Werner, Rascol, Olivier, Marek, Kenneth
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lancet Pub. Group 2013
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3714436/ https://www.ncbi.nlm.nih.gov/pubmed/23726851 http://dx.doi.org/10.1016/S1474-4422(13)70117-0

Ejemplares similares

Minimal Clinically Important Difference in Parkinson's Disease as Assessed in Pivotal Trials of Pramipexole Extended Release
por: Hauser, Robert A., et al.
Publicado: (2014)

Long-term safety and sustained efficacy of extended-release pramipexole in early and advanced Parkinson's disease
por: Hauser, R A, et al.
Publicado: (2014)

Role and clinical utility of pramipexole extended release in the treatment of early Parkinson’s disease
por: Hametner, Eva-Maria, et al.
Publicado: (2012)

This proud heart
por: Buck, Pearl S. (Pearl Sydenstricker), 1892-1973
Publicado: (1943)

P2B001 (Extended Release Pramipexole and Rasagiline): A New Treatment Option in Development for Parkinson’s Disease
por: Hauser, Robert A., et al.
Publicado: (2022)

Pramipexole Reduces Phosphorylation of α-Synuclein at Serine-129
por: Chau, Kai-Yin, et al.
Publicado: (2013)

Dramatic Response to Pramipexole in Delayed-Onset Parkinsonism from Osmotic Demyelinating Syndrome
por: Han, Steve C., et al.
Publicado: (2020)

Sushrutha - our proud heritage
por: Bhattacharya, Surajit
Publicado: (2009)

We are proud of you Jamie
por: Azoulay, Elie, et al.
Publicado: (2022)

“PROUD to have been involved”: an evaluation of participant and community involvement in the PROUD HIV prevention trial
por: Gafos, Mitzy, et al.
Publicado: (2020)

Update on the use of pramipexole in the treatment of Parkinson’s disease
por: Constantinescu, Radu
Publicado: (2008)

Dyskinesias and Treatment with Pramipexole in Patients with Parkinson's Disease
por: Piedad, John C. P., et al.
Publicado: (2012)

“Makes you proud to be black eh?”: Reflections on meaningful Indigenous research participation
por: Kelly, Jenny, et al.
Publicado: (2012)

Taro Okamoto's proud message : the road to completion of "tomorrow's myth"
por: Okamoto, Taro, 1911-1996
Publicado: (2006)

Recent developments in biomarkers in Parkinson disease
por: Schapira, Anthony H.V.
Publicado: (2013)

Automatic behavior and communication due to pramipexole
por: Walker, Ruth H.
Publicado: (2016)

Pramipexole and its Extended Release Formulation for Parkinson’s Disease
por: Fishman, Paul S.
Publicado: (2011)

Analysis of pramipexole dose–response relationships in Parkinson’s disease
por: Wang, Ying, et al.
Publicado: (2016)

Pramipexole Inhibits Neuronal Apoptosis in Rats with Parkinson's Disease
por: Sun, Yongqi, et al.
Publicado: (2022)

Pramipexole Extended Release: A Novel Treatment Option in Parkinson's Disease
por: Eisenreich, Wolfram, et al.
Publicado: (2010)

Pramipexole use and the risk of pneumonia
por: Ernst, Pierre, et al.
Publicado: (2012)

Pramipexole: new use for an old drug – the potential use of pramipexole in the treatment of restless legs syndrome
por: Benbir, Gulcin, et al.
Publicado: (2006)

Beneficial effect of pramipexole for motor function and depression in Parkinson’s disease
por: Kano, Osamu, et al.
Publicado: (2008)

Retracted: Pramipexole Inhibits Neuronal Apoptosis in Rats with Parkinson's Disease
por: Healthcare Engineering, Journal of
Publicado: (2023)

Burning mouth syndrome responsive to pramipexol
por: Stuginski-Barbosa, J., et al.
Publicado: (2008)

Reply: long-term retention rate of pramipexole in the treatment of Parkinson’s disease
por: Arbouw, Maurits E. L., et al.
Publicado: (2009)

Possible effects of pramipexole on neck muscles in a patient with Parkinson's disease
por: Filippi, Roberto, et al.
Publicado: (2014)

SOT at 50: A Proud Legacy, A Vibrant Future
por: Birnbaum, Linda S.
Publicado: (2011)

Death Be Not Proud—Cell Death Control in Plant Fungal Interactions
por: Dickman, Martin B., et al.
Publicado: (2013)

Design of the PROUD study: PCR faeces testing in outpatients with diarrhoea
por: Schierenberg, Alwin, et al.
Publicado: (2016)

Proud Syndrome: A Rare Cause of Corpus Callosum Agenesis
por: Devi, Risha, et al.
Publicado: (2023)

JACC: Asia Proudly Recognizes the 2022 Young Author Awardees
por: Wang, Jian’an
Publicado: (2023)

Mitochondria-targeted antioxidant effects of S(-) and R(+) pramipexole
por: Ferrari-Toninelli, Giulia, et al.
Publicado: (2010)

Gold nanoclusters as prospective carriers and detectors of pramipexole
por: Si, Nguyen Thanh, et al.
Publicado: (2021)

Patient considerations in early management of Parkinson’s disease: focus on extended-release pramipexole
por: Salawu, Fatai Kunle
Publicado: (2012)

Pramipexole-induced antecollis in patients with Parkinson's disease: Two cases and literature review
por: Iijima, Mutsumi, et al.
Publicado: (2015)

JCHIMP: A proud 4 year old with the best yet to come
por: Ferguson, Robert P.
Publicado: (2014)

Ain’t Too Proud to Beg! Effects of Leader’s Use of Pride on Groups
por: Daus, Catherine S., et al.
Publicado: (2020)

Martin Woodrow: 'I think the profession has done itself proud'
Publicado: (2021)

A prospective cohort study of depression (PROUD) in China: rationale and design
por: Zhou, Jingjing, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_6lf7f9qiorm3s26cmuuqlr2olu